Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Registration - In-house Corporation

LEO PHARMA INC. / Jill Archibald, General Manager

Registration Information

In-house Corporation name: LEO PHARMA INC.
Responsible Officer Name: Jill Archibald, General Manager 
Responsible Officer Change History
Initial registration start date: 1999-02-12
Registration status: Active
Registration Number: 952071-12014

Associated Communications

Total Number of Communication Reports: 9

Monthly communication reports in the last 6 months: 0

Version 1 of 8 (1999-02-12 to 2000-02-29)

Version 1 of 8 (1999-02-12 to 2000-02-29) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.

A. Information about Lobbyist and Corporation

Corporation: LEO PHARMA INC.
555 KINGSTON ROAD WEST
AJAX, ON  L1S 6M1
Canada
Telephone number: 905-427-8828
Fax number: 905-427-8161  
Responsible officer name and position during the period of this registration: GREGORY C HINES, PRESIDENT  
Description of activities: MY EMPLOYER IS A BRAND NAME PHARMACEUTICAL MANUFACTURER (PRESCRIPTION DRUGS).
 
Parent: The corporation is not a subsidiary of any other parent corporations.
Coalition The corporation is not a member of a coalition.
Subsidiary: The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking.
Other direct interests The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
 
Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? No
 

B. Lobbying Activity Information

Federal departments or organizations which have been or will be communicated with during the course of the undertaking: Canadian International Trade Tribunal (CITT), Finance Canada (FIN), Foreign Affairs and International Trade Canada (DFAITC), Health Canada (HC), Industry Canada, National Research Council (NRC), Patented Medicine Prices Review Board (PMPRB), Treasury Board Of Canada Secretariat (TBS)
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format
 
Subject Matter: Areas of Concern: PHARMACEUTICALS
 
Subject Matter: Particulars: LEGISLATIVE PROPOSALS:PATENT ACT REGULATIONS: HPB: BUREAU OF PRESCRIPTION DRUGS, NEW DRUG LICENSING PRACTICES PATENTED MEDICINE PRICES REVIEW BOARD, HOME PHARMA CARE, LINKAGE REEGULATIONS



Responsible Officer Name

This is the responsible officer name as provided in the most recent registration for the corporation or organization.

Name Change History:

LEO PHARMA INC.

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name From To
LEO PHARMA INC. 2018-08-24 current

The following names have been used before July 2, 2008

  • LEO PHARMA INC.

Responsible Officer Change History

LEO PHARMA INC.

Responsible Officer History
Responsible Officer Name From (YYYY-MM-DD) To (YYYY-MM-DD)
Jill Archibald 2022-04-25 Current
Goncalo Goya 2021-08-16 2022-04-25
Kristian Fick 2018-08-24 2020-06-16
GREGORY HINES 1999-02-12 2000-02-29

All Monthly Communication Reports for LEO PHARMA INC.

Jill Archibald, General Manager (Corporation)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-9 of 9

  • LEO PHARMA INC.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Dr. Stephen Ellis, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2023-08-03
    Posted date: 2023-10-03
    Communication number: 12014-577542 View associated registration
  • LEO PHARMA INC.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mitch Davies, Sr Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director | Innovation, Science and Economic Development Canada (ISED)
    • Jocelyn Milburn, Officer | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry
    Communication date: 2019-12-05
    Posted date: 2019-12-16
    Communication number: 12014-461840 View associated registration
  • LEO PHARMA INC.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rodrigo Arancibia, Director | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2019-11-21
    Posted date: 2019-12-16
    Communication number: 12014-461847 View associated registration
  • LEO PHARMA INC.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • David Lee, Chief Regulatory Officer | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2019-06-12
    Posted date: 2019-07-02
    Communication number: 12014-456610 View associated registration
  • LEO PHARMA INC.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Supriya Sharma, Chief Medical Advisor, HC / Senior Medical Advisor for HPFB | Health Canada (HC)
    • Marcel Saulnier, Associate ADM | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2019-05-08
    Posted date: 2019-05-24
    Communication number: 12014-453534 View associated registration
  • LEO PHARMA INC.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Arthur Lam, Sr Advisor | MINISTER OF SMALL BUSINESS AND EXPORT PROMOTION | Innovation, Science and Economic Development Canada (ISED)
    • Emily Yorke, Policy Advisor | Finance Canada (FIN)
    • Janet MacPhee, Senior Investment Officer | Global Affairs Canada (GAC)
    • Zoe Hawa, Deputy Director | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health
    Communication date: 2019-02-26
    Posted date: 2019-03-01
    Communication number: 12014-446332 View associated registration
  • LEO PHARMA INC.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Kate Moussouni, Senior Policy Advisor | Health Canada (HC)
    • Rodrigo Arancibia, Director, Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)
    • Benoit Leduc, Manager | Innovation, Science and Economic Development Canada (ISED)
    • Kate Proctor, Policy Advisor | Treasury Board Of Canada Secretariat (TBS)
    • Kevin Deagle, Policy Advisor | Indigenous Services Canada (ISC)
    • Joseph Wabegijig, Policy Advisor | Indigenous Services Canada (ISC)

    Subject Matter of the communication: Health
    Communication date: 2018-11-16
    Posted date: 2018-11-30
    Communication number: 12014-440528 View associated registration
  • LEO PHARMA INC.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mary Ng, Member of Parliament | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2018-10-09
    Posted date: 2018-10-16
    Communication number: 12014-436135 View associated registration
  • LEO PHARMA INC.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • John Oliver, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2018-08-27
    Posted date: 2018-08-30
    Communication number: 12014-432933 View associated registration

Public offices held:


Date Modified: